Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 34, Issue 3, 2016, Pages 416-423

  Holmström, Miia ^a   Koivuniemi, Riitta ^a   Korpi, Kirsi ^a   Kaasalainen, Touko ^a   Laine, Mika ^a   Kuuliala, Antti ^a   Leirisalo Repo, Marjatta ^a   Kupari, Markku ^a   Kivistö, Sari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cardiac magnetic resonance; Cardiovascular disease; Late gadolinium enhancement; Rheumatoid arthritis; T1 mapping

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GADOLINIUM; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CASE CONTROL STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FILLING; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART VOLUME; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MAJOR CLINICAL STUDY; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; ONSET AGE; PRIORITY JOURNAL; RELAXATION TIME; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SJOEGREN SYNDROME; UNIVARIATE ANALYSIS; ARTHRITIS, RHEUMATOID; COMPLICATION; ETIOLOGY; FINLAND; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT ACUITY; PROCEDURES; STATISTICAL ANALYSIS; TIME;

AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FINLAND; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MIDDLE AGED; PATIENT ACUITY; STROKE VOLUME; TIME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84982834529     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. MAVROGENI S, DIMITROULAS T, SFIKAKIS PP, KITAS GD: Heart Involvement in rheumatoid arthritis: Multimodality imaging and the emerging role of cardiac magnetic resonance. Semin Arthritis Rheum 2013; 43: 314-24.
2. VOSKUYL AE: The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatol 2006; 45: iv4-7.
3. CORRAO S, MESSINA S, PISTONE G, CALVO L, SCAGLIONE R, LICATA G: Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 2013; 167: 2031-8.
4. CORRAO S, SALLÌ L, ARNONE S, et al.: Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease. Eur Heart J 1995; 16: 253-6.
5. ASLAM F, BANDEALI SJ, KHAN NA, ALAM M: Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 2013; 65: 534-43.
6. CORRAO S, ARGANO C, PISTONE G, MESSINA S, CALVO L, PERTICONE F: Rheumatoid arthritis affects left ventricular mass: Systematic review and meta-analysis. Eur J Intern Med 2015; 26: 259-67.
7. GILES J, FERNANDES V, LIMA JA, BATHON JM: Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 2005; 7: 195-207.
8. GRUNDTMAN C, HOLLAN I, FORRE OT, SAATVEDT K, MIKKELSEN K, LUNDBERG IE: Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes. Arthritis Rheum 2010; 62: 667-73.
9. HOLLAN I, MERONI PL, AHEARN JM, et al.: Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 2013; 12: 1004-15.
10. GILES JT, FERT-BOBER J, PARK JK, et al.: Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Rheum 2012; 14: R39.
11. KOIVUNIEMI R, PAIMELA L, SUOMALAINEN R, LEIRISALO-REPO M: Cardiovascular diseases in patients with rheumatoid arthritis. Scand J Rheumatol 2013; 42: 131-5.
12. NICOLA PJ, CROWSON CS, MARADIT-KREMERS H, et al.: Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006; 54: 60-7.
13. MARADIT-KREMERS H, NICOLA PJ, CROWSON CS, BALLMAN KV, SHERINE EG: Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
14. KOBAYASHI Y, GILES JT, HIRANO M, et al.: Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 2010; 12: R171.
15. OZEN G, DIRESKENELI H, INANC N: Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis. Clin Exp Rheumatol 2014; 32 (Suppl. 87): S16-7.
16. ROSALES-ALEXANDER JL, SALVATIERRA J, LLORCA J, et al.: Cardiovascular risk assessment in rheumatoid arthritis: impact of the EULAR recommendations on a national calibrated score risk index. Clin Exp Rheumatol 2014; 32: 237-42.
17. MAKSIMOVIC R, SEFEROVIC PM, RISTIC AD, et al.: Cardiac imaging in rheumatic diseases. Rheumatol 2006; 45 (Suppl. 4): iv26-31.
18. MAVROGENI S, DIMITROULAS T, KITAS GD: Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 2012; 12: 305-12.
19. FINE NM, CROWSON CS, LIN G, OH JK, VILLARRAGA HR, GABRIEL SE: Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckletracking echocardiography. Ann Rheum Dis 2014; 73: 1833-9.
20. FURER V, FAYAD ZA, MANI V, CALCAGNO C, FARKOUH ME, GREENBERG JD: Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging. Semin Arthritis Rheum 2012; 41: 676-88.
21. NTUSI N, PIECHNIK S, FRANCIS J, et al.: Diffuse myocardial fibrosis and inflammation in Rheumatoid Arthritis. Insights From CMR T1 Mapping. J Am Coll Cardiol 2015; 8: 526-36.
22. DABIR D, CHILD N, KALRA A, et al.: Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014; 16: 69.
23. MAESTRINI V, TREIBEL TA, WHITE SK, FONTANA M, MOON JC: T1 Mapping for characterization of intracellular and extracellular myocardial diseases in heart failure. Curr Cardiovasc Imaging Rep 2014; 7: 9287.
24. PUNTMANN VO, VOIGT T, CHEN Z, et al.: Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. J Am Coll Cardiol Img 2013; 6: 475-84.
25. FERREIRA VM, PIECHNIK SK, DALL'ARMELLINA E, et al.: Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson 2014; 16: 36.
26. PICA S, SADO DM, MAESTRINI V, et al.: Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2014; 16: 99.
27. PUNTMANN VO, D'CRUZ D, SMITH Z, et al.: Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013; 6: 295-301.
28. CERQUEIRA MD, WEISSMAN NJ, DILSIZIAN V, et al.: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002; 105: 539-42.
29. KOBAYASHI Y, KOBAYASHI H, HIRANO M, GILES JT: Left ventricular regional dysfunction using cardiac magnetic resonance imaging in rheumatoid arthritis patients without cardiac symptoms: comparison between methotrexate and biologics treatment groups. J Rheumatol 2014; 41: 1560-2.
30. KARAMITSOS TD, PIECHNIK SK, BANYPERSAD SM, et al.: Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. J Am Coll Cardiol Img 2013; 6: 497.
31. MOON JC, MESSROGHLI DR, KELLMAN P, et al.: Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013; 15: 92.
32. MAHRHOLDT H, WAGNER A, JUDD RM, SECHTEM U, KIM RJ: Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-74.
33. TZELEPIS GE, KELEKIS NL, PLASTIRAS SC, et al.: Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007; 56: 3827-36.
34. MAVROGENI S, BRATIS K, MARKUSSIS V, et al.: The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013; 22: 34-43.
35. MAVROGENI S, SFIKAKIS PP, GIALAFOS E, et al.: Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res 2014; 66: 104-12.
36. CORRAO S, SALLÌ L, ARNONE S, SCAGLIONE R, PINTO A, LICATA G: Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 1996; 26: 293-73.
37. BAKTIR AO, SARLI B, CEBICCI MA, et al.: Preclinical impairment of myocardial function in rheumatoid arthritis patients: Detection of myocardial strain by speckle tracking echocardiography. Herz 2015; 40: 669-7.
38. SCHAU T, GOTTWALD M, ARBACH O, et al.: Increased prevalence of diastoloc herat failure in patients with rheumatoid arthritis correlates with active disease, but not with treatment type. J Rheumatol 2015; 42: 2029-37.
39. JELLIS C, YINGCHONCHAROEN T, AYACHE A, FLAMM S, KWON D: Right ventricular T1 mapping is technically feasible and correlates with right ventricular dysfunction in non-ischemic cardiomyopathy. J Cardiovasc Magn Reson [abstract] 2014; 16 (Suppl. 1): P336.
40. FRIEDRICH MG, SECHTEM U, SCHULZMENGER J, et al.: Cardiac magnetic resonance in myocarditis. A JACC white paper. J Am Coll Cardiol 2009; 53: 1475-87.